Jump to content

20250179462. Factor Ix Polypeptide M (uniQure biopharma B.V.)

From WikiPatents

FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION

Abstract: disclosed are a modified fix (factor ix) polypeptide comprising a leucine, cysteine, aspartic acid, glutamic acid, histidine, lysine, asparagine, glutamine or tyrosine in position 338; pharmaceutical preparations containing said modified fix polypeptide; a nucleotide sequence coding for the modified fix polypeptide; and a method for producing the modified fix polypeptide.

Inventor(s): Paolo SIMIONI

CPC Classification: C12N9/644 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media ))

Search for rejections for patent application number 20250179462


Cookies help us deliver our services. By using our services, you agree to our use of cookies.